Screening for brain metastases (BM) in patients (pts) with stage III non-small cell lung cancer (NSCLC), magnetic resonance imaging (MRI) or dedicated contrast-enhanced computed tomography (dCE-CT)? A prospective observational study

Autor:	Dirk De Ruysscher, M. De Booij, R. Houben, Wendy Schreurs, Lizza E.L. Hendriks, A-M.C. Dingemans, G. Bootsma, Paul Hofman, Marcel Westenend, Janna Schoenmaekers
Rok vydání:	2018
Předmět:	Brachial Plexus Neuritis medicine.diagnostic_test business.industry media_common.quotation_subject Computed tomography Magnetic resonance imaging Hematology Stage III Non-Small Cell Lung Cancer Oncology medicine Contrast (vision) In patient Observational study Nuclear medicine business media_common
Zdroj:	Annals of Oncology. 29:viii488-viii489
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy291.002
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d0900625e13412eebb8b51fd5062f2e6 https://doi.org/10.1093/annonc/mdy291.002 Zobrazit plný text záznamu